Presentation TCT 2013 Optimal Management of Multivessel Disease in Patients Undergoing Primary PCI: Design and Rationale of the Multinational COMPLETE Trial Presenter: Shamir Mehta October 30, 2013 REGISTER for free or LOG IN to view this content ACS/AMI Presentation TCT 2013 Up Next Presentation TCT 2013 Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than... Presenter: Daniel Blackman October 30, 2013 More slides + Presentation TCT 2013 Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know Presenter: Robert Schwartz October 31, 2013 Presentation TCT 2013 Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development Presenter: Michael Joner October 31, 2013 We Recommend
Presentation TCT 2013 Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than... Presenter: Daniel Blackman October 30, 2013
Presentation TCT 2013 Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know Presenter: Robert Schwartz October 31, 2013
Presentation TCT 2013 Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development Presenter: Michael Joner October 31, 2013